Keros Therapeutics, Inc. (KROS)

NASDAQ: KROS · IEX Real-Time Price · USD

48.38

+0.36 (0.75%)

At close: Jul 19, 2024, 4:00 PM

48.35

-0.03 (-0.06%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Keros Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Revenue	0.23	0.15	0	20.1	0	10	Upgrade
Gross Profit	0.23	0.15	0	20.1	0	10	Upgrade
Selling, General & Admin	37.36	34.83	27.53	21.33	12.8	3.18	Upgrade
Research & Development	142.43	135.26	87.27	55.14	33.86	17.38	Upgrade
Operating Expenses	179.79	170.09	114.79	76.47	46.66	20.56	Upgrade
Operating Income	-179.56	-169.94	-114.79	-56.37	-46.66	-10.56	Upgrade
Interest Expense / Income	0	0	0	0	0.01	0.01	Upgrade
Other Expense / Income	-19.25	-16.95	-10.11	0.36	-1.13	3.57	Upgrade
Pretax Income	-160.3	-152.99	-104.68	-56.73	-45.53	-14.14	Upgrade
Income Tax	0	0	0	2.01	-0.17	0	Upgrade
Net Income	-160.3	-152.99	-104.68	-58.74	-45.36	-14.14	Upgrade
Shares Outstanding (Basic)	36	29	25	23	16	2	Upgrade
Shares Outstanding (Diluted)	36	29	25	23	16	2	Upgrade
Shares Change	25.79%	16.66%	8.17%	50.48%	566.41%	7.01%	Upgrade
EPS (Basic)	-5.15	-5.20	-4.15	-2.52	-2.93	-6.08	Upgrade
EPS (Diluted)	-5.15	-5.20	-4.15	-2.52	-2.93	-6.08	Upgrade
Free Cash Flow	-137.18	-126.97	-71.3	-63.17	-37.19	-16.27	Upgrade
Free Cash Flow Per Share	-3.84	-4.31	-2.83	-2.71	-2.40	-6.99	Upgrade
Gross Margin	100.00%	100.00%	-	100.00%	-	100.00%	Upgrade
Operating Margin	-76732.91%	-112543.71%	-	-280.46%	-	-105.63%	Upgrade
Profit Margin	-68505.13%	-101319.21%	-	-292.26%	-	-141.36%	Upgrade
Free Cash Flow Margin	-58624.36%	-84087.42%	-	-314.29%	-	-162.69%	Upgrade
EBITDA	-158.01	-150.63	-103.06	-55.83	-44.92	-13.69	Upgrade
EBITDA Margin	-67524.79%	-99751.66%	-	-277.77%	-	-136.90%	Upgrade
Depreciation & Amortization	2.29	2.37	1.62	0.9	0.61	0.44	Upgrade
EBIT	-160.3	-152.99	-104.68	-56.73	-45.53	-14.13	Upgrade
EBIT Margin	-68505.13%	-101319.21%	-	-282.23%	-	-141.28%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).